Medical Research


At CAF, Medical Reseach is Key


Medical researchers who are interested in initiating a thalassemia-related project or who have an existing project that requries additional funding: The Cooley’s Anemia Foundation may be just what you need. CAF is now accepting applications for its 2016-2017 Fellowship and Research Grant programs and we encourage you to apply.

CAF has a decades-long history of supporting innovative and important research in thalassemia. Our established and respected Medical Fellowship program has funded numerous early career individuals who have continued to stay in the thalassemia field and make important contributions to the scientific and clinical study of thalassemia.

Our Support for Ongoing Clinical Research in Thalassemia Grants and Clinical Trials in Thalassemia Cell and GeneTherapy Grants are aggressively pushing forward the understanding of issues of concern to the growing thalassemia population and helping to propel advances in areas of primary importance.

CAF Accepting Applications for 2017 Medical Research Fellowships and Grants

Tuesday, October 4th, 2016

October 4, 2016 – The Cooley’s Anemia Foundation is accepting applications for medical research grants and fellowships in areas related to thalassemia.  The awards are in 3 categories: Support for Ongoing Clinical Research in Thalassemia;  Clinical Trials in Thalassemia Cell and Gene Therapy;  and Research Fellowships. Details are as follows: SUPPORT FOR ONGOING CLINICAL RESEARCH […]

CAF Awards $202,500 Funding in Medical Research Fellowships

Tuesday, September 27th, 2016

September 27, 2016- CAF is pleased to announce that four new Cooley’s Anemia Foundation Medical Research Fellowships and one renewal Fellowship have been awarded for the 2016-2017 grant cycle. In addition, this year we have awarded a new Clinical Research Grant to support ongoing clinical research in thalassemia. The total amount of funding for the […]

CAF Accepting Applications for 2016 Research Grants and Fellowships

Thursday, November 12th, 2015

November 6, 2015 – The Cooley’s Anemia Foundation is accepting applications for medical research grants and fellowships in areas related to thalassemia.  The awards are in 3 categories: Support for Ongoing Clinical Research in Thalassemia;  Clinical Trials in Thalassemia Cell and Gene Therapy;  and Research Fellowships. Details are as follows: SUPPORT FOR ONGOING CLINICAL RESEARCH […]

10th Cooley’s Anemia Symposium a Resounding Success

Wednesday, October 28th, 2015

October 28, 2015 – A packed house of 240 clinicians, scientists, nurses, industry, consumers and other participants attended the 10th Cooley’s Anemia Symposium in Rosemont, IL from October 18-22. This invaluable meeting, presented by the Cooley’s Anemia Foundation (CAF) and the New York Academy of Sciences(NYAS)  is an anticipated and milestone event held only every […]

CAF Awards $195,000 Funding in Medical Research Fellowships

Thursday, July 30th, 2015

July 29, 2015 – Three new Cooley’s Anemia Foundation Medical Research Fellowships have been awarded for the 2015-2016 grant cycle. Combined with the three Fellowships which have been renewed from the previous cycle, the total amount of research funding for the current cycle comes to $195,000. The recipients were selected by members of the CAF […]

TIF Establishes Renzo Galanello Training Fellowship

Monday, February 2nd, 2015

February 2, 2015 – Thalassaemia International Federation ( TIF) has announced a new thalassemia fellowship opportunity, established in honor of the late Renzo Galanello, Professor of Pediatrics at the University of Cagliari, Italy, and Director of the 2nd Pediatric Clinic, Department of Biomedical Sciences and Biotechnologies, Ospedale Regionale per le Microcitemie.  Dr. Galanello was a respected and […]

CAF Applauds Advances in Thalassemia Reported at Annual Hematology Meeting

Thursday, December 11th, 2014

December 11, 2014 – Exciting data from studies looking at new treatments for thalassemia presented at the annual meeting of the American Society of Hematology builds upon science supported by the Cooley’s Anemia Foundation and gives hope for the development of significant new treatments for the genetic blood disorder known as thalassemia. Two of the […]

CAF’s $300,000 Medical Research Funding Moves Field Forward

Tuesday, August 26th, 2014

August 25, 2014 – New explorations in gene editing. Connections between thyroid hormones and hemoglobin. Efficiency and safety in gene therapy. Using a protein to control iron. These are the ideas behind the four exciting new studies being funded by the Cooley’s Anemia Foundation this year. These new fellowships join four renewed fellowships and a […]

bluebird bio’s Northstar Study in Gene Transfer

Tuesday, December 17th, 2013

bluebird bio, a Cambridge, MA- based biotechnology company, is sponsoring the Northstar Study, investigating gene transfer as a curative option for beta-thalassemia. More information about the study, including eligibility requirements, can be found at  http:///www.northstarstudy.com. The Northstar Study is now enrolling adults who are transfusion dependent and diagnosed with a beta thalassemia major. The goal […]

bluebird bio Announces First Patient Transplanted in Phase 1/2 HGB-205 Study for the Treatment of Beta-Thalassemia and Sickle Cell Anemia

Tuesday, December 3rd, 2013

December 2, 2013 – bluebird bio, Inc. today announced that the first subject with beta-thalassemia major has been enrolled in its phase 1/2 HGB-205 study in France and has undergone infusion with bluebird bio’s LentiGlobin drug product in an autologous hematopoietic stem cell transplantation. “We believe gene therapy represents a potentially new and exciting treatment […]